These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
5. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162 [TBL] [Abstract][Full Text] [Related]
6. DNA binding to mouse cells is mediated by cell-surface molecules: the role of these DNA-binding molecules as target antigens in murine lupus. Hefeneider SH; McCoy SL; Morton JI; Bakke AC; Cornell KA; Brown LE; Bennett RM Lupus; 1992 May; 1(3):167-73. PubMed ID: 1301977 [TBL] [Abstract][Full Text] [Related]
7. Catalytic antibodies in clinical and experimental pathology: human and mouse models. Ponomarenko NA; Durova OM; Vorobiev II; Aleksandrova ES; Telegin GB; Chamborant OG; Sidorik LL; Suchkov SV; Alekberova ZS; Gnuchev NV; Gabibov AG J Immunol Methods; 2002 Nov; 269(1-2):197-211. PubMed ID: 12379362 [TBL] [Abstract][Full Text] [Related]
8. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978 [TBL] [Abstract][Full Text] [Related]
9. [DNA-abzymes and their clinical significance in systemic lupus erythematosis]. Suchkov SV; Gabibov AG; Alekberova ZS; Gnuchev NV Ter Arkh; 2001; 73(10):58-65. PubMed ID: 11763520 [TBL] [Abstract][Full Text] [Related]
10. Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors. Andryushkova AA; Kuznetsova IA; Bineva VN; Toporkova LB; Sakhno LV; Tikhonova MA; Chernykh ER; Orlovskaya IA; Nevinsky GA J Cell Mol Med; 2007; 11(3):531-51. PubMed ID: 17635644 [TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Eivazova ER; McDonnell JM; Sutton BJ; Staines NA Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885 [TBL] [Abstract][Full Text] [Related]
13. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. Deocharan B; Qing X; Lichauco J; Putterman C J Immunol; 2002 Mar; 168(6):3072-8. PubMed ID: 11884481 [TBL] [Abstract][Full Text] [Related]
14. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity. Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429 [TBL] [Abstract][Full Text] [Related]
15. Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice. Dieker J; Hilbrands L; Thielen A; Dijkman H; Berden JH; van der Vlag J Arthritis Res Ther; 2015 Apr; 17(1):103. PubMed ID: 25886192 [TBL] [Abstract][Full Text] [Related]
16. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice]. Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365 [TBL] [Abstract][Full Text] [Related]
17. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus. Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050 [TBL] [Abstract][Full Text] [Related]
18. Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops. Ward FJ; Knies JE; Cunningham C; Harris WJ; Staines NA Immunology; 1997 Nov; 92(3):354-61. PubMed ID: 9486108 [TBL] [Abstract][Full Text] [Related]
19. Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice. Andryushkova AA; Kuznetsova IA; Orlovskaya IA; Buneva VN; Nevinsky GA Int Immunol; 2009 Aug; 21(8):935-45. PubMed ID: 19556305 [TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]